(Total Views: 242)
Posted On: 03/13/2017 4:53:38 PM
Post# of 15624
ok, here is something you already know:
GW Pharmaceuticals plc GWPH reported first-quarter fiscal 2017 loss of 77 cents per share, much narrower than both the Zacks Consensus Estimate of a loss of $1.35 and the year-ago figure of 82 cents.
interesting that gwph trades at 123pps+...
25 million in o/s-no doubt...still a loss of 77 cents per share.
once owcp starts having revenues coming in....
and product after product is successful(yes, my hope)...my opinion is: the sky is the limit....imo..
GW Pharmaceuticals plc GWPH reported first-quarter fiscal 2017 loss of 77 cents per share, much narrower than both the Zacks Consensus Estimate of a loss of $1.35 and the year-ago figure of 82 cents.
interesting that gwph trades at 123pps+...
25 million in o/s-no doubt...still a loss of 77 cents per share.
once owcp starts having revenues coming in....
and product after product is successful(yes, my hope)...my opinion is: the sky is the limit....imo..
(1)
(0)Scroll down for more posts ▼
